Interactions between ES-miRNAs and environmental risk factors are responsible for TNBC progression and associated racial health disparities: a novel analysis with multilevel moderation inferences
Interactions between ES-miRNAs and environmental risk factors are responsible for TNBC progression and associated racial health disparities: a novel analysis with multilevel moderation inferences
批准号:
10594746
负责人:
Yaguang Xi
金额:
$33.63万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-01-01 至 2027-12-31
关键词:
AcuteAddressAffectAfrican AmericanAfrican American populationAnimal ModelBioinformaticsBiologicalBloodBreast Cancer CellBreast Cancer PatientBreast Cancer cell lineCancer PatientCancer PrognosisCause of DeathCharacteristicsChronicDataDevelopmentDiagnosisDisease ProgressionDistant MetastasisElementsEnvironmentEnvironmental ExposureEnvironmental Risk FactorEpidemiologyEthnic OriginEthnic PopulationExposure toGenesGoalsHigh PrevalenceHumanIn VitroIncidenceIndividualInheritedLinkLipidsLouisianaMalignant NeoplasmsMeasuresMediatingMediationMessenger RNAMetastatic breast cancerMethodsMicroRNAsModelingMolecular BiologyNeighborhoodsNeoplasm MetastasisOncogenicOutcomePatientsPhysical environmentPlayPopulationPrognosisProteinsRaceRecurrenceReportingRoleSamplingSocial EnvironmentSocioeconomic StatusStromal CellsStructureSurvival RateTumor PromotionTumor-DerivedUnited StatesVisceral metastasisWomanXenograft procedurebreast cancer progressioncaucasian Americanclinical translationcohortepidemiology studyexosomehealth care availabilityhealth disparityin vivo Modelinnovationinsightmalignant breast neoplasmmiRNA expression profilingmortalityneoplastic cellnoveloutcome predictionpatient derived xenograft modelpredictive modelingracial disparityracial health disparityracial populationregression treesrisk predictionsocialsocioeconomicsstatisticstriple-negative invasive breast carcinomatumortumor microenvironmenttumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary:
For women in the United States, breast cancer is not only the most common malignancy but also the second
leading cause of death. In this application, we focus on a specific subtype of breast cancer known as triple-
negative breast cancer (TNBC). Because TNBC has a higher recurrence rate and poorer overall mortality than
other subtypes of breast cancer, it is more aggressive and extremely difficult to treat with standard therapies.
Epidemiological studies have clearly shown that African American (AA) women are more likely to develop
advanced TNBC than Caucasian American (CA) women. For instance, in Louisiana (LA), where we live, from
2010 to 2017, there were 3,790 TNBC cases, of which 1,861 (49.1%) were from the AA population versus 1,900
(50.1%) were from the CA population, while 32.8% of the LA population were AA and 62.8% were CA. Notably,
43.5% of the AA patients were diagnosed with regional or distant metastasis, compared with 36.6% of CA
patients. Thus, TNBC represents a significant challenge to racial health disparities in Louisiana. The overall goal
of this project is to determine the extent to which modifiable factors in the neighborhood physical and social
environment affect the prognosis of TNBC patients and whether their effects can be accurately reflected and
quantified through detectable biological variables. Recent studies have revealed that tumor-derived exosomes
(TDEs) play a prominent role in promoting tumor progression and metastasis. TDEs contain many oncogenic
elements, including multiple miRNAs, mRNAs, proteins, and lipids. Notably, exosomal miRNAs (ES-miRs) have
been reported to be critical for crosstalk between tumor cells and stromal cells in the tumor microenvironment
(TME) and the establishment of pre-metastatic niches. Therefore, we hypothesize that ES-miRs are biological
variables that not only reflect and quantify the effects of environmental risk factors associated with racial
health disparities, but are also functionally involved in the progression of TNBC. Our specific aims are as
follows: Aim 1: Use multilevel mediation and moderation analysis to identify significant ES-miRs and
environmental risk factors for TNBC progression and understand how their interactions explain racial health
disparities in TNBC. Aim 2: Validate the function of selected ES-miRs in TNBC progression using in vitro and in
vivo models. Aim 3: Develop a new model to predict TNBC progression in AA and CA patients. We expect that
our study can develop an innovative approach to quantify adverse physical and social environmental influences
on the progression of TNBC across different races and provide insights into the development of more effective
strategies to reduce racial health disparities in TNBC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing LG007 as a novel therapeutic agent to treat triple negative breast cancer
-
批准号:10889411
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2023
-
负责人:Yaguang Xi
-
依托单位:
Sulindac sensitizes colorectal cancer to anti-PD-L1 therapy
-
批准号:10889412
-
项目类别:
-
资助金额:$56.3万
-
财政年份:2023
-
负责人:Yaguang Xi
-
依托单位:
MiR-17 mediates sulindac anti-metastatic activity in human colorectal cancer
-
批准号:10258119
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Yaguang Xi
-
依托单位:
Sulindac sensitizes colorectal cancer to anti-PD-L1 therapy
-
批准号:10538823
-
项目类别:
-
资助金额:$55.38万
-
财政年份:2022
-
负责人:Yaguang Xi
-
依托单位:
Investigate interactive roles of environmental, behavioral and genetic factors on racial disparities in breast cancer outcomes
-
批准号:10655049
-
项目类别:
-
资助金额:$11.03万
-
财政年份:2021
-
负责人:Yaguang Xi
-
依托单位:
Developing LG007 as a novel therapeutic agent to treat triple negative breast cancer
-
批准号:10477444
-
项目类别:
-
资助金额:$37.39万
-
财政年份:2021
-
负责人:Yaguang Xi
-
依托单位:
Developing LG007 as a novel therapeutic agent to treat triple negative breast cancer
-
批准号:10313128
-
项目类别:
-
资助金额:$38.15万
-
财政年份:2021
-
负责人:Yaguang Xi
-
依托单位:
MicroRNA and colorectal cancer chemoprevention
-
批准号:9325302
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2015
-
负责人:Yaguang Xi
-
依托单位:
MicroRNA and colorectal cancer chemoprevention
-
批准号:9313603
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2015
-
负责人:Yaguang Xi
-
依托单位:
MicroRNA, a new player for the NSAID sulindac to prevent colon cancer progression
-
批准号:8707735
-
项目类别:
-
资助金额:$19.71万
-
财政年份:2014
-
负责人:Yaguang Xi
-
依托单位:
MicroRNA, a new player for the NSAID sulindac to prevent colon cancer progression
-
批准号:8836988
-
项目类别:
-
资助金额:$4.71万
-
财政年份:2014
-
负责人:Yaguang Xi
-
依托单位:
海外基金